Cimetidine as an adjuvant treatment in colorectal cancer : a double-blind, randomized pilot study

To evaluate the influence of a H2 receptor antagonist (cimetidine) on survival in patients with colorectal carcinoma, a randomized, controlled pilot study was performed in three university hospitals in Copenhagen, Denmark. A total of 192 patients, who had undergone a resection or an exploratory oper...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diseases of the colon & rectum 1995-05, Vol.38 (5), p.514-518
Hauptverfasser:	SVENDSEN, L. B, ROSS, C, KNIGGE, U, FREDERIKSEN, H. J, GRAVERSEN, P, KJAERGARD, J, LUKE, M, STIMPEL, H, SPARSØ, B. H
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - mortality Adenocarcinoma - surgery Adult Aged Aged, 80 and over Biological and medical sciences Chemotherapy, Adjuvant Cimetidine - therapeutic use Colonic Neoplasms - drug therapy Colonic Neoplasms - mortality Colonic Neoplasms - surgery Denmark - epidemiology Digestive system Double-Blind Method Female Follow-Up Studies Humans Male Medical sciences Middle Aged Pharmacology. Drug treatments Pilot Projects Placebos Rectal Neoplasms - drug therapy Rectal Neoplasms - mortality Rectal Neoplasms - surgery Survival Rate Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!